Virtus Family Office’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-3,316
Closed -$960K 44
2022
Q3
$960K Buy
+3,316
New +$960K 2.45% 12